Fondazione I.R.C.C.S. Policlinico San Matteo
Fondazione I.R.C.C.S. Policlinico San Matteo
Pavia, Italy2 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Ivosidenib (IVO) Monotherapy and Azacitidine (AZA) Monotherapy in Patients With Hypomethylating Agent (HMA) Naive Myelodysplastic Syndromes (MDS) With an IDH1 Mutation | Hemic and Lymphatic Diseases, bone marrow disorder, hematologic disorder, myelodysplastic syndrome | Recruiting | Phase 3 | 2026-09-03 | NCT06465953 | |
| BRCA Mutation Carriers' Platform a Multicenter Study | BRCA1 Mutation; BRCA2 Mutation | Recruiting | Not stated | 2025-11-28 | NCT07253051 |